rs75171342
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_000091.5(COL4A3):c.1030-18G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00122 in 1,558,444 control chromosomes in the GnomAD database, including 29 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0015 ( 4 hom., cov: 33)
Exomes 𝑓: 0.0012 ( 25 hom. )
Consequence
COL4A3
NM_000091.5 intron
NM_000091.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.561
Publications
1 publications found
Genes affected
COL4A3 (HGNC:2204): (collagen type IV alpha 3 chain) Type IV collagen, the major structural component of basement membranes, is a multimeric protein composed of 3 alpha subunits. These subunits are encoded by 6 different genes, alpha 1 through alpha 6, each of which can form a triple helix structure with 2 other subunits to form type IV collagen. This gene encodes alpha 3. In the Goodpasture syndrome, autoantibodies bind to the collagen molecules in the basement membranes of alveoli and glomeruli. The epitopes that elicit these autoantibodies are localized largely to the non-collagenous C-terminal domain of the protein. A specific kinase phosphorylates amino acids in this same C-terminal region and the expression of this kinase is upregulated during pathogenesis. This gene is also linked to an autosomal recessive form of Alport syndrome. The mutations contributing to this syndrome are also located within the exons that encode this C-terminal region. Like the other members of the type IV collagen gene family, this gene is organized in a head-to-head conformation with another type IV collagen gene so that each gene pair shares a common promoter. [provided by RefSeq, Jun 2010]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (REVEL=0.007).
BP6
Variant 2-227259775-G-A is Benign according to our data. Variant chr2-227259775-G-A is described in ClinVar as Benign. ClinVar VariationId is 254974.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.00152 (231/152280) while in subpopulation EAS AF = 0.0374 (194/5182). AF 95% confidence interval is 0.0331. There are 4 homozygotes in GnomAd4. There are 124 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 4 AD,AR,SD gene
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| COL4A3 | NM_000091.5 | c.1030-18G>A | intron_variant | Intron 18 of 51 | ENST00000396578.8 | NP_000082.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| COL4A3 | ENST00000396578.8 | c.1030-18G>A | intron_variant | Intron 18 of 51 | 1 | NM_000091.5 | ENSP00000379823.3 |
Frequencies
GnomAD3 genomes AF: 0.00153 AC: 233AN: 152162Hom.: 4 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
233
AN:
152162
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00320 AC: 797AN: 249302 AF XY: 0.00285 show subpopulations
GnomAD2 exomes
AF:
AC:
797
AN:
249302
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00119 AC: 1677AN: 1406164Hom.: 25 Cov.: 25 AF XY: 0.00117 AC XY: 826AN XY: 703310 show subpopulations
GnomAD4 exome
AF:
AC:
1677
AN:
1406164
Hom.:
Cov.:
25
AF XY:
AC XY:
826
AN XY:
703310
show subpopulations
African (AFR)
AF:
AC:
4
AN:
32344
American (AMR)
AF:
AC:
2
AN:
44634
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
25824
East Asian (EAS)
AF:
AC:
1307
AN:
39398
South Asian (SAS)
AF:
AC:
102
AN:
85112
European-Finnish (FIN)
AF:
AC:
1
AN:
53392
Middle Eastern (MID)
AF:
AC:
2
AN:
5670
European-Non Finnish (NFE)
AF:
AC:
93
AN:
1061338
Other (OTH)
AF:
AC:
166
AN:
58452
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
76
152
227
303
379
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
30
60
90
120
150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00152 AC: 231AN: 152280Hom.: 4 Cov.: 33 AF XY: 0.00167 AC XY: 124AN XY: 74452 show subpopulations
GnomAD4 genome
AF:
AC:
231
AN:
152280
Hom.:
Cov.:
33
AF XY:
AC XY:
124
AN XY:
74452
show subpopulations
African (AFR)
AF:
AC:
11
AN:
41564
American (AMR)
AF:
AC:
1
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3470
East Asian (EAS)
AF:
AC:
194
AN:
5182
South Asian (SAS)
AF:
AC:
11
AN:
4824
European-Finnish (FIN)
AF:
AC:
0
AN:
10608
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
10
AN:
68018
Other (OTH)
AF:
AC:
4
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
12
25
37
50
62
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
45
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
not provided Benign:1
Jan 23, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.